• Product name

  • Description

    Rabbit polyclonal to SUCLA2
  • Host species

  • Tested applications

    Suitable for: WBmore details
  • Species reactivity

    Reacts with: Mouse, Human
    Predicted to work with: Rat, Sheep, Rabbit, Horse, Cow, Pig, Chimpanzee, Macaque monkey, Gorilla, Chinese hamster, Orangutan
  • Immunogen

    Synthetic peptide within Human SUCLA2 aa 50-150 conjugated to keyhole limpet haemocyanin. The exact sequence is proprietary.
    Database link: Q9P2R7

  • Positive control

    • This antibody gave a positive signal in the following tissue lysates: Human Heart; Human Mitochondrial Heart ; Mouse Heart; Mouse Liver as well as both HepG2 and MOLT4 whole cell lysates.



Our Abpromise guarantee covers the use of ab190845 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/250. Detects a band of approximately 45 kDa (predicted molecular weight: 50 kDa).


  • Function

    Catalyzes the ATP-dependent ligation of succinate and CoA to form succinyl-CoA.
  • Tissue specificity

    Widely expressed. Not expressed in liver and lung.
  • Pathway

    Carbohydrate metabolism; tricarboxylic acid cycle; succinate from succinyl-CoA (ligase route): step 1/1.
  • Involvement in disease

    Mitochondrial DNA depletion syndrome 5
  • Sequence similarities

    Belongs to the succinate/malate CoA ligase beta subunit family.
    Contains 1 ATP-grasp domain.
  • Cellular localization

  • Information by UniProt
  • Database links

  • Alternative names

    • A BETA antibody
    • A SCS antibody
    • ATP specific succinyl CoA synthetase subunit beta antibody
    • ATP specific succinyl CoA synthetase, beta subunit antibody
    • ATP-specific succinyl-CoA synthetase subunit beta antibody
    • Mitochondrial succinyl CoA ligase [ADP forming] subunit beta antibody
    • MTDPS5 antibody
    • Renal carcinoma antigen NY-REN-39 antibody
    • Renal carcinoma antigen NYREN39 antibody
    • SCS betaA antibody
    • SCS-betaA antibody
    • SUCB1_HUMAN antibody
    • Succinate CoA ligase (ADP forming) antibody
    • Succinate CoA ligase [ADP forming] subunit beta, mitochondrial; succinyl CoA ligase [ADP forming] subunit beta, mitochondrial antibody
    • Succinate CoA ligase ADP forming beta subunit antibody
    • Succinate CoA ligase beta subunit antibody
    • Succinyl CoA ligase [ADP-forming] subunit beta, mitochondrial antibody
    • Succinyl CoA synthetase beta A chain antibody
    • Succinyl-CoA ligase [ADP-forming] subunit beta, mitochondrial antibody
    • Succinyl-CoA synthetase beta-A chain antibody
    • SUCLA2 antibody
    see all


  • All lanes : Anti-SUCLA2 antibody (ab190845) at 1 µg/ml

    Lane 1 : Human heart tissue lysate - total protein (ab29431)
    Lane 2 : Human Heart Mitochondrial Lysate
    Lane 3 : Heart (Mouse) Tissue Lysate
    Lane 4 : Liver (Mouse) Tissue Lysate
    Lane 5 : HepG2 (Human hepatocellular liver carcinoma cell line) Whole Cell Lysate
    Lane 6 : MOLT4 (Human acute lymphoblastic leukemia cell line) Whole Cell Lysate

    Lysates/proteins at 10 µg per lane.

    All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/10000 dilution

    Developed using the ECL technique.

    Performed under reducing conditions.

    Predicted band size: 50 kDa
    Observed band size: 45 kDa
    why is the actual band size different from the predicted?
    Additional bands at: 16 kDa (possible non-specific binding)

    Exposure time: 30 seconds

    The band observed at 45 kDa could potentially be a cleaved form of SUCLA2 due to the presence of 52 amino acid Transit peptide.

    This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 5% Bovine Serum Albumin before being incubated with ab190845 overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP, and visualised using ECL development solution.


ab190845 has not yet been referenced specifically in any publications.

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab190845.
Please use the links above to contact us or submit feedback about this product.

For licensing inquiries, please contact partnerships@abcam.com

Sign up